These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6608007)

  • 1. Role of T-lymphocyte subsets in recovery from herpes simplex virus infection.
    Larsen HS; Feng MF; Horohov DW; Moore RN; Rouse BT
    J Virol; 1984 Apr; 50(1):56-9. PubMed ID: 6608007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.
    Nash AA; Jayasuriya A; Phelan J; Cobbold SP; Waldmann H; Prospero T
    J Gen Virol; 1987 Mar; 68 ( Pt 3)():825-33. PubMed ID: 2950204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane phenotype of murine effector and suppressor T cells involved in delayed hypersensitivity and protective immunity to herpes simplex virus.
    Nash AA; Gell PG
    Cell Immunol; 1983 Feb; 75(2):348-55. PubMed ID: 6219750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
    Rouse BT; Miller LS; Turtinen L; Moore RN
    J Immunol; 1985 Feb; 134(2):926-30. PubMed ID: 2981270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split T-cell tolerance in herpes simplex virus-infected mice and its implication for anti-viral immunity.
    Nash AA; Ashford NP
    Immunology; 1982 Apr; 45(4):761-7. PubMed ID: 6279490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery from lethal herpes simplex virus type 1 infection is mediated by cytotoxic T lymphocytes.
    Larsen HS; Russell RG; Rouse BT
    Infect Immun; 1983 Jul; 41(1):197-204. PubMed ID: 6305838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
    Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
    J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The augmentation of tumor-specific immunity by virus help. III. Enhanced generation of tumor-specific Lyt-1+2- T cells is responsible for augmented tumor immunity in vivo.
    Yoshioka T; Fukuzawa M; Takai Y; Wakamiya N; Ueda S; Kato S; Fujiwara H; Hamaoka T
    Cancer Immunol Immunother; 1986; 21(3):193-8. PubMed ID: 2938736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do L3T4+ T cells act as effector cells in protection against influenza virus infection.
    Lightman S; Cobbold S; Waldmann H; Askonas BA
    Immunology; 1987 Sep; 62(1):139-44. PubMed ID: 2820868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
    Schrier RD; Ishioka GY; Pizer LI; Moorhead JW
    J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells.
    Staats HF; Oakes JE; Lausch RN
    J Virol; 1991 Nov; 65(11):6008-14. PubMed ID: 1920624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in herpes simplex virus-infected mice: H-2 mapping of the delayed-type hypersensitivity response and the antiviral T cell response.
    Nash AA; Phelan J; Wildy P
    J Immunol; 1981 Apr; 126(4):1260-2. PubMed ID: 6259256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to herpes simplex virus type 2. Suppression of virus-induced immune responses in ultraviolet B-irradiated mice.
    Yasumoto S; Hayashi Y; Aurelian L
    J Immunol; 1987 Oct; 139(8):2788-93. PubMed ID: 2821119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
    Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
    Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell effector function and unresponsiveness in the murine lymphocytic choriomeningitis virus infection. II. Delayed-type hypersensitivity unresponsiveness reflects a defective differentiation from TD precursor to effector cell.
    Thomsen AR; Marker O
    Scand J Immunol; 1986 Aug; 24(2):137-45. PubMed ID: 3489281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses.
    Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T
    J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Lyt-1 positive immune T cells in recovery from herpes simplex virus infection in mice.
    Nagafuchi S; Hayashida I; Higa K; Wada T; Mori R
    Microbiol Immunol; 1982; 26(4):359-62. PubMed ID: 6287182
    [No Abstract]   [Full Text] [Related]  

  • 20. Selective expression of the Ly-6C.2 epitope on Lyt-2+ T cells that can develop in the absence of thymic influence.
    Leo O; Foo M; Forman J; Shivakumar S; Rabinowitz R; Bluestone JA
    J Immunol; 1988 Jul; 141(1):37-44. PubMed ID: 2454263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.